Get the tools used by (smart)2 investors.

Total Debt / Total Capital for Integra LifeSciences Holdings

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

IART: Integra LifeSciences Holdings

Integra LifeSciences Holdings Corporation manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolary...

16.81 USD
Price
USD
Fair Value
Upside
14.45 - 32.66
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Integra LifeSciences Holdings's Total Debt / Total Capital:

Dec 2016Dec 2018Dec 2020Dec 2022Dec 202430.0%50.0%70.0%

Performance Summary
  • Integra LifeSciences's latest twelve months total debt / total capital is 60.6%
  • Integra LifeSciences's total debt / total capital for fiscal years ending December 2020 to 2024 averaged 33.6%.
  • Integra LifeSciences's operated at median total debt / total capital of 26.8% from fiscal years ending December 2020 to 2024.
  • Looking back at the last 5 years, Integra LifeSciences's total debt / total capital peaked in December 2024 at 60.6%.
  • Integra LifeSciences's total debt / total capital hit its 5-year low in December 2021 of 23.2%.
  • Integra LifeSciences's total debt / total capital decreased in 2020 (24.0%, -0.6%) and 2021 (23.2%, -3.4%) and increased in 2022 (26.8%, +15.5%), 2023 (33.2%, +23.8%), and 2024 (60.6%, +82.8%).

How does Integra's Total Debt / Total Capital benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Integra LifeSciences Holdings because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: Total Debt / Total Capital

Hide this widget
debt_to_capital
Slug
number
Datatype
text
Format
current
Default Period
FY, LTM
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Total Debt / Total Capital in the risk category include:

  • Cash Flow / Total Debt - A ratio used in two ways - a) to measure cash flow coverage and b) the inverse ratio to estimate the length of time needed to pay off debts.
  • Long-term Debt / Equity - A ratio that measures the level of the long-term debt relative to the book value of common equity.
  • Net Debt / Total Capital - A ratio that measures the level of the net debt relative to the market value of total capital. Net debt is the sum of all long term debt fields minus cash and short-term investments.
  • Realized Volatility (90d Annualized) - Realized volatility (also known as rolling volatility) over the last 90 days.
View Full List

Search for metric or datapoint

Total Debt / Total Capital

A ratio that measures the level of the debt relative to the market value of total capital.

Definition of Total Debt / Total Capital

Hide this widget

Total Debt / Total Capital is defined as:

Total Capital = Market Cap + Total Debt
Total Debt / Total Capital = Total Debt / Total Capital

The higher the percentage, the more debt the company has in its capital structure and the lower the equity cushion. In times of distress, a high Debt / Total Capital increases the chances of default or bankruptcy.


Click the link below to download a spreadsheet with an example Total Debt / Total Capital calculation for Integra LifeSciences Holdings below:

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
0.0%25.0%50.0%94.8%0200400600

The chart above depicts the distribution of total debt / total capital for companies operating in the Healthcare sector in the Developed economic region. Over 2,350 companies were considered in this analysis, and 2,309 had meaningful values. The average total debt / total capital of companies in the sector is 19.3% with a standard deviation of 23.1%.

Integra LifeSciences Holdings's Total Debt / Total Capital of 60.6% ranks in the 91.6% percentile for the sector. The following table provides additional summary stats:

Total Debt / Total Capital In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,356
Included Constituents2,309
Min0.0%
Max94.7%
Median9.6%
Mean19.3%
Standard Deviation23.1%

You can find companies with similar total debt / total capital using this stock screener.

All rights reserved. Terms Of Use